Health Canada details cannabis method validation and delta-8 separation expectations

New Health Canada guidance recommends that laboratories validate representative product matrices, sufficiently separate delta-8 THC from delta-9 THC, document uncertainty and avoid overstating precision on certificates of analysis. Although Canadian, the guidance gives Oklahoma labs and manufacturers a transferable checklist for method validation, synthesized-cannabinoid interference and defensible COA reporting.